Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about ADAM10: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
ADAM10 (A Disintegrin and Metalloproteinase 10) is the primary alpha-secretase in the non-amyloidogenic processing pathway of amyloid precursor protein (APP). Cleavage by ADAM10 occurs within the Abeta domain, preventing the formation of amyloid-beta peptides and generating the neuroprotective sAPPalpha fragment. ADAM10 is a transmembrane protein belonging to the ADAM family, widely expressed in brain tissue with particularly high activity in neurons. Genetic variants in ADAM10 have been associated with susceptibility to late-onset Alzheimer's disease, and rare pathogenic mutations (including nonsense mutations like Tyr167*) have been identified in familial AD cases. Therapeutic strategies targeting ADAM10 include promoting its activity to shift APP processing away from the amyloidogenic pathway, though no ADAM10-based therapies have yet reached clinical use. ADAM10 also processes other substrates including Notch, TNF-alpha, and ErbB4, making its biology complex and context-dependent.
No AI portrait yet
| Gene Symbol | ADAM10 |
| Full Name | A Disintegrin And Metalloproteinase Domain 10 |
| Aliases | Kuzbanian, CD156c |
| Chromosome | 15q21.3 |
| Function | Alpha-secretase, cleaves APP via non-amyloidogenic pathway |
| Molecular Weight | 84.1 kDa |
| Amino Acids | 748 |
| Pathways | Non-amyloidogenic APP processing, Notch signaling |
| UniProt ID | O14672 |
| NCBI Gene ID | 102 |
| Ensembl ID | ENSG00000137845 |
| OMIM | 602192 |
| GeneCards | ADAM10 |
| Human Protein Atlas | ADAM10 |
| Associated Diseases | AGING, Als, Alzheimer, Cancer, Dementia |
| Interactions | ACAT1, AD, ADAM17, ADAMTS4, AGING, AKT |
| KG Connections | 459 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
graph TD
ADAM10["ADAM10"] -->|"biomarker for"| Alzheimer_s_Disease["Alzheimer's Disease"]
style Alzheimer_s_Disease fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#e0e0e0
ADAM10["ADAM10"] -->|"regulates"| Notch_pathway["Notch pathway"]
style Notch_pathway fill:#1a2a3a,stroke:#81c784,stroke-width:1px,color:#e0e0e0
ADAM10["ADAM10"] -->|"activates"| NLGN3["NLGN3"]
style NLGN3 fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
ADAM10["ADAM10"] -->|"associated"| Alzheimer["Alzheimer"]
style Alzheimer fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#e0e0e0
ADAM10["ADAM10"] -->|"associated"| Ms["Ms"]
style Ms fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#e0e0e0
ADAM10["ADAM10"] -->|"therapeutic target"| Inflammation["Inflammation"]
style Inflammation fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#e0e0e0
ADAM10["ADAM10"] -->|"therapeutic target"| Als["Als"]
style Als fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#e0e0e0
TREM2["TREM2"] -.->|"inhibits"| ADAM10["ADAM10"]
style TREM2 fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#e0e0e0
GENES["GENES"] -->|"therapeutic target"| ADAM10["ADAM10"]
style GENES fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#e0e0e0
CAPN1["CAPN1"] -->|"therapeutic target"| ADAM10["ADAM10"]
style CAPN1 fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#e0e0e0
TTR["TTR"] -->|"therapeutic target"| ADAM10["ADAM10"]
style TTR fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#e0e0e0
LGALS3["LGALS3"] -->|"therapeutic target"| ADAM10["ADAM10"]
style LGALS3 fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#e0e0e0
style ADAM10 fill:#006494,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0,font-weight:bold| Target | Relation | Type | Str |
|---|---|---|---|
| benchmark_ot_ad_answer_key:ADAM10 | data_in | dataset_row | 0.00 |
| ds-83b31ef18d49 | provides_data_for | dataset | 1.00 |
| Alzheimer's Disease | biomarker_for | disease | 0.95 |
| Notch pathway | regulates | pathway | 0.90 |
| DAM microglia | expressed_in | cell_type | 0.75 |
| NEP | inhibits | gene | 0.70 |
| BACE1 | protects_against | gene | 0.70 |
| GABAERGIC | activates | cell_type | 0.70 |
| NRF2 | expresses | gene | 0.70 |
| NOTCH | degrades | gene | 0.70 |
| RAGE | activates | gene | 0.70 |
| NEURONS | activates | cell_type | 0.70 |
| TAU | expresses | gene | 0.70 |
| PSEN1 | expresses | gene | 0.70 |
| CDK5 | expresses | gene | 0.70 |
| APP | expresses | gene | 0.70 |
| PSEN1 | inhibits | gene | 0.70 |
| CX3CR1 | regulates | gene | 0.70 |
| CX3CL1 | regulates | gene | 0.70 |
| NLGN3 | activates | protein | 0.70 |
| NLGN3 | regulates | protein | 0.70 |
| CYP46A1 | inhibits | gene | 0.70 |
| AMYLOID | regulates | protein | 0.70 |
| Neurodegeneration | activates | disease | 0.65 |
| Alzheimer | activates | disease | 0.65 |
| Ms | activates | disease | 0.65 |
| Ischemia | activates | disease | 0.65 |
| Parkinson | activates | disease | 0.65 |
| Neuroinflammation | activates | disease | 0.65 |
| Inflammation | activates | disease | 0.65 |
| APP | degrades | gene | 0.65 |
| APP | inhibits | gene | 0.65 |
| BACE1 | interacts_with | gene | 0.65 |
| Als | activates | disease | 0.65 |
| Aging | activates | disease | 0.65 |
| Als | biomarker_for | disease | 0.65 |
| Cancer | expressed_in | disease | 0.65 |
| Liver Cancer | biomarker_for | disease | 0.65 |
| Als | associated_with | disease | 0.65 |
| Cancer | regulates | disease | 0.65 |
| Multiple Sclerosis | regulates | disease | 0.65 |
| Alzheimer | regulates | disease | 0.65 |
| AMYLOID PLAQUES | produces | phenotype | 0.65 |
| AMYLOID PLAQUES | interacts_with | phenotype | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Inflammation | therapeutic_target | disease | 0.65 |
| AMYLOID | produces | protein | 0.65 |
| AMYLOID | causes | protein | 0.65 |
| Autoimmune | regulates | disease | 0.65 |
| Huntington | inhibits | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| benchmark_ot_ad_answer_key:ADAM10 | data_in | dataset_row | 0.00 |
| entities-app-protein | interacts_with | wiki | 0.00 |
| ds-83b31ef18d49 | data_in | dataset | 1.00 |
| genes-adam10 | describes | wiki_page | 0.95 |
| h-trem2-fe8c644a | targets_gene | hypothesis | 0.90 |
| ALZHEIMER'S DISEASE | associated_with | disease | 0.74 |
| APP | produces | gene | 0.70 |
| TREM2 | protects_against | gene | 0.70 |
| TEMPORAL LOBE | causes | brain_region | 0.70 |
| TNF | regulates | gene | 0.70 |
| TNF | degrades | gene | 0.70 |
| TNF | inhibits | gene | 0.70 |
| TEMPORAL LOBE | activates | brain_region | 0.70 |
| MITOPHAGY | regulates | phenotype | 0.65 |
| APOPTOSIS | regulates | phenotype | 0.65 |
| ERK | causes | gene | 0.65 |
| ERK | treats | gene | 0.65 |
| NEURONS | inhibits | cell_type | 0.65 |
| AXL | interacts_with | gene | 0.65 |
| CORTEX | activates | brain_region | 0.65 |
| APP | causes | gene | 0.65 |
| MTOR | activates | gene | 0.60 |
| AD | interacts_with | gene | 0.60 |
| ACHE | regulates | gene | 0.60 |
| GRN | associated_with | gene | 0.60 |
| MICROGLIA | inhibits | gene | 0.60 |
| AMYLOID-Β PLAQUES | inhibits | gene | 0.60 |
| ALZHEIMER'S DISEASE | inhibits | gene | 0.60 |
| ASTROCYTES | inhibits | gene | 0.60 |
| APP/PS1 | activates | gene | 0.60 |
| CANCER | expressed_in | gene | 0.60 |
| ERK | activates | gene | 0.60 |
| NEURON | activates | gene | 0.60 |
| HIF1A | therapeutic_target | gene | 0.60 |
| GRIN1 | therapeutic_target | gene | 0.60 |
| PLCB4 | activates | gene | 0.60 |
| APLP2 | activates | gene | 0.60 |
| APLP1 | activates | gene | 0.60 |
| AKT | activates | gene | 0.60 |
| APP | activates | gene | 0.60 |
| UBIQUITIN | inhibits | gene | 0.60 |
| HSP70 | inhibits | gene | 0.60 |
| TAU | inhibits | gene | 0.60 |
| GFAP | activates | gene | 0.60 |
| NLGN3 | inhibits | gene | 0.60 |
| SORL1 | associated_with | gene | 0.60 |
| ABCA7 | associated_with | gene | 0.60 |
| GBA | associated_with | gene | 0.60 |
| DDX1 | associated_with | gene | 0.60 |
| CANCER | associated_with | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
neurodegeneration | 2026-04-04 | 15 hypotheses Top: 0.814
neurodegeneration | 2026-04-03 | 45 hypotheses Top: 0.990
neurodegeneration | 2026-04-02 | 5 hypotheses Top: 0.761
neurodegeneration | 2026-04-02 | 7 hypotheses Top: 0.741
neurodegeneration | 2026-04-01 | 12 hypotheses Top: 0.921
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
closed · Rounds: 4 · Score: 0.90 · 2026-04-12
closed · Rounds: 5 · Score: 0.93 · 2026-04-11
closed · Rounds: 3 · Score: 0.95 · 2026-04-04
closed · Rounds: 4 · Score: 0.95 · 2026-04-03
closed · Rounds: 3 · Score: 0.68 · 2026-04-02
closed · Rounds: 4 · Score: 0.89 · 2026-04-02